[email protected]
CAS 56977-92-5 (R,R)-(-)-1,2-BIS[(O-METHOXYPHENYL)(PHENYL)PHOSPHINO]ETHANE(1,5-CYCLOOCTADIENE)RHODIUM (I) TETRAFLUOROBORATE molecular structure lightbox
CAS RN: 56977-92-5

(R,R)-(-)-1,2-BIS[(O-METHOXYPHENYL)(PHENYL)PHOSPHINO]ETHANE(1,5-CYCLOOCTADIENE)RHODIUM (I) TETRAFLUOROBORATE

Product Availability

Choose a grade to view its available package options.

1 package records0 with current stock1 grade group
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20260614 25mg / 50mg / 100mg Out of stock 8-10 business days Inquiry
  • Product code: starshine_CAS56977-92-5
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

56977-92-5 / cycloocta-1,5-diene;(2-methoxyphenyl)-[2-[(2-methoxyphenyl)-phenylphosphanyl]ethyl]-phenylphosphane;rhodium;tetrafluoroborate

Standard CAS: 56977-92-5 Multi CAS: Yes
Basic Information Computed Properties

Basic Information

CAS
56977-92-5
Multi CAS
Yes
Molecular Formula
BC36F4H40O2P2Rh
Molecular Weight
756.400000
Exact Mass
756.158770
InChI
InChI=1S/C28H28O2P2.C8H12.BF4.Rh/c1-29-25-17-9-11-19-27(25)31(23-13-5-3-6-14-23)21-22-32(24-15-7-4-8-16-24)28-20-12-10-18-26(28)30-2;1-2-4-6-8-7-5-3-1;2-1(3,4)5;/h3-20H,21-22H2,1-2H3;1-2,7-8H,3-6H2;;/q;;-1;
InChIKey
DCGUTTVLWMBBAX-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
46
Aromatic heavy atom count
24
Fraction Csp3
0.22
Rotatable bonds
9
H-bond acceptors
2
Molar refractivity
187.92
TPSA
18.46

LogP / Solubility

WLOGP
9.24
MLOGP
8.2
XLogP3
9.24
Consensus LogP
8.89
Log S (ESOL)
-10.14
Class (ESOL)
Insoluble
Log S (Ali)
-12.43
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-13.33
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-0.77

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
6

Customers Also Viewed

Get In Touch

Contact Us